32
Participants
Start Date
June 1, 2004
Primary Completion Date
October 1, 2008
Study Completion Date
October 1, 2008
Albumin-bound paclitaxel
Administered by intravenous infusion.
Carboplatin
Carboplatin dose was calculated using a modified Calvert formula (creatinine clearance was substituted for GFR): Total dose (mg) = (target AUC) x (creatinine clearance + 25). Note: AUC = 6 was initially targeted, but could be decreased due to toxicity.
Herceptin®
Administered by IV infusion
Lombardi Cancer Center Georgetown University Hospital, Washington D.C.
Memorial Sloan-Kettering Cancer Center, New York
University of Pittsburgh Medical Center Magee Womens Hospital, Pittsburgh
Washington Hospital Center, Washington D.C.
Gerogia Cancer Specialist, Atlanta
Palm Beach Cancer Institute, West Palm Beach
Gulf Coast Oncology Associates, St. Petersburg
Florida Cancer Institute, Hudson
Southwest Regional Cancer Center, Austin
Breastlink Med Group, Long Beach
Swedish Medical Center Cancer Institute Research, Seattle
Hematology/Oncology P.C. Carl & Dorothy Bennet Cancer Center, Stamford
Maine Center for Cancer Medicine and Blood Disorders, Scarborough
Rhode Island Hospital, Providence
Lead Sponsor
Celgene
INDUSTRY